Latest News
Nov 30, 2022
Propanc Biopharma Concludes PRP Could Become an Effective Chemosensitizer Agent Against Pancreatic CancerPRP May Help Overcome Growth of Fibrotic Tissue Surrounding Resistant Tumors MELBOURNE, Australia--(BUSINESS WIRE)-- Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a…
View All Press Releases